De Bacci Capital Hosts Fundraising Reception for Rua Diagnostics in Dubai

De Bacci Capital was honored to host an exclusive fundraising reception in Dubai for Rua Diagnostics, a pioneering healthcare company reshaping the future of medical testing.

The evening brought together esteemed family offices, venture capital firms, investment banks, and global investors from the De Bacci Capital’s exclusive network to explore this transformative opportunity in the MedTech sector.

Held in an atmosphere of refinement and purpose, the reception highlighted the unique potential of Rua’s breakthrough diagnostic platform, which offers fast, painless, and highly accurate results based on a single breath sample.

The event underscored both the ethical commitment and investment value behind a venture that promises to redefine access to healthcare worldwide.

About Rua Diagnostics

Rua Diagnostics is a healthcare startup transforming diagnostics with a portable breath analysis platform that delivers fast, AI-powered results for multiple conditions through a single, non-invasive breath sample. Designed for any care setting — from hospitals to clinics and even remote environments — the technology aims to expand access to early detection, ultimately saving lives and reducing costs across healthcare systems.

The device is built upon advanced micro gas chromatography technology developed at the University of Michigan. By detecting specific compounds in exhaled breath, Rua opens a new frontier in diagnostics: identifying diseases with speed, precision, and unparalleled ease of use.

• Sector: MedTech, Healthcare

• Stage: Developed working prototypes successfully validated in clinical research across multiple conditions

• Market: $800B global diagnostics market; $20B U.S. point-of-care segment

• Projected Revenue: $600M by 2030 (U.S. market alone)

• ROI: 6,425% based on a 20x multiple of pre-tax earnings in 2030

• Capital Raise: $25M

• Minimum Investment: $1M

A Noble Vision Meets Global Health Innovation

Rua Diagnostics aligns with De Bacci Capital’s vision of supporting ventures that not only yield financial success but also advance human well-being. By enabling early detection across multiple serious health conditions, Rua’s platform has the potential to save both thousands of lives and billions of dollars in healthcare costs worldwide.

The evening concluded with a resounding call to action: Rua invites discerning investors and capital providers to join this groundbreaking journey — one that blends innovation, impact, and extraordinary financial potential.

Rua Diagnostics is more than an investment. It is a step toward a healthier, more equitable future.

Pitch deck is available upon request.

For inquiries, please email us: admin@debacciofficial.org

Join our dealflow platform and become part of a legacy that is shaping the future of global business: https://www.dfx-dbc.com

Disclaimer: The content of this website is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. Readers should carefully consider whether investing in the given product is appropriate for them based on their financial circumstances, consider the risks, and seek independent consultation.